Khái niệm tế bào gốc của vú

Cohnheim J (1882) Vorlesung über die allgemeine Pathologie, 1. Bd., Berlin, S 736 Potter VR (1978) Phenotypic diversity in experimental hepatomas: The concept of partially blocked ontogeny. The 10th Walter Hubert Lecture. Br J Cancer 38(1):1–23 Russo IH, Russo J (1998) Role of hormones in mammary cancer initiation and progression. J Mammary Gland Biol Neoplasia 3(1):49–61 Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer and cancer stem cells. Nature 414:105–111 Rody A, Karn T, Holtrich U, Kaufmann M (2008) Stem cell like breast cancers-a model for the identification of new prognostic/predictive markers in endocrine responsive breast cancer exemplified by Plexin B1. Eur J Obstet Gynecol Reprod Biol 139(1):11–15 Kaufmann M, Rody A, Brustkrebs (2009) Mortalitätsreduktion durch Früherkennung und adjuvante Therapie. Geburtsh Frauenheilk (im Druck) Sørlie T, Perou CM, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98(19):10869–10874 Vogelstein B, Fearon ER, Hamilton SR et al (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319:525–532 Lakhani SR (1999) The transition from hyperplasia to invasive carcinoma of the breast. J Pathol 187:272–278 Boecker W, Buerger H, Schmitz K et al (2001) Ductal epithelial proliferations of the breast: A biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns. J Pathol 195(4):415–421 Boecker W, Moll R, Dervan P et al (2002) Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ. J Pathol 198(4):458–467 Rakha EA, Putti TC, Abd El-Rehim DM et al (2006) Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. J Pathol 208(4):495–506 Martínez-Climent JA, Andreu EJ, Prosper F (2006) Somatic stem cells and the origin of cancer. Clin Transl Oncol 8:647–663 Graziano A, d’Aquino R, Tirino V et al (2008) The stem cell hypothesis in head and neck cancer. J Cell Biochem 103:408–412 Dontu G, Abdallah WM, Foley JM et al (2003) In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17(10):1253–1270 Molyneux G, Regan J, Smalley MJ (2007) Mammary stem cells and breast cancer. Cell Mol Life Sci 64(24):3248–3260 Clarke RB, Spence K, Anderson E et al (2005) A putative human breast stem cell population is enriched for steroid receptor-positive cells. Dev Biol 277:443–456 Cairns J (2006) Cancer and the immortal strand hypothesis. Genetics 174:1069–1072 Smith GH (2005) Label-retaining epithelial cells in mouse mammary gland divide asymmetrically and retain their template DNA strands. Development 132:681–687 Welm BE, Tepera SB, Venezia T et al (2002) Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev Biol 245:42–56 Gudjonsson T et al (2002) Isolation, immortalization and characterization of a human breast epithelial cell line with stem cell properties. Genes Dev 16:693–706 Stingl J, Eirew P, Ricketson I et al (2006) Purification and unique properties of mammary epithelial stem cells. Nature 439:993–997 Shackleton M, Vaillant F, Simpson KJ et al (2006) Generation of a functional mammary gland from a single stem cell. Nature 439:84–88 Asselin-Labat M, Shackleton M, Stingl J et al (2006) Steroid hormone receptor status of mouse mammary stem cells. J Natl Cancer Inst 98:1011–1014 Sleeman KE, Kendrick H, Robertson D et al (2007) Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland. J Cell Biol 176:19–26 Clarke RB, Howell A, Potten CS, Anderson E (1997) Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 57:4987–4991 Singh SK, Clarke ID, Terasaki M et al (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63(18):5821–5828 Wright MH, Calcagno AM, Salcido CD et al (2008) Brca1 breast tumors contain distinct CD44+/CD24− and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res 10(1):R10 Kalirai H, Clarke RB (2006) Human breast epithelial stem cells and their regulation. J Pathol 208(1):7–16 Kakarala M, Wicha MS, Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. J Clin Oncol 26(17):2813–2820 Jones DL, Wagers AJ (2008) No place like home: Anatomy and function of the stem cell niche. Nat Rev Mol Cell Biol 9(1):11–21 Woodward WA, Chen MS, Behbod F, Rosen JM (2005) On mammary stem cells. J Cell Sci 118(Pt 16):3585–3594 Stumpf WE, Narbaitz R, Sar M (1980) Estrogen receptors in the fetal mouse. J Steroid Biochem 12:55–64 Brisken C, Heineman A, Chavarria T et al (2000) Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev 14(6):650–654 Daniel CW, Silberstein GB, Strickland P (1987) Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography. Cancer Res 47(22):6052–6057 Mallepell S, Krust A, Chambon P, Brisken C (2006) Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland. Proc Natl Acad Sci U S A 103(7):2196–2201 Savarese TM, Strohsnitter WC, Low HP et al (2007) Correlation of umbilical cord blood hormones and growth factors with stem cell potential: Implications for the prenatal origin of breast cancer hypothesis. Breast Cancer Res 9(3):R29 Dontu G, Abdallah WM, Foley JM et al (2003) In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17(10):1253–1270 Ahlgren M, Melbye M, Wohlfahrt J, Sørensen T (2004) Growth patterns and the risk of breast cancer in women. N Engl J Med 351:1619–1626 van Garderen E, Schalken JA (2002) Morphogenic and tumorigenic potentials of the mammary growth hormone/growth hormone receptor system. Mol Cell Endocrinol 197(1–2):153–165 de Visser KE, Eichten A, Coussens LM (2006) Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6(1):24–37 Kohrt HE, Nouri N, Nowels K et al (2005) Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer. PLoS Med 2(9):e284 Ménard S, Tomasic G, Casalini P et al (1997) Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas. Clin Cancer Res 3(5):817–819 Rody A, Holtrich U, Pusztai L et al (2009) T-cell metagene predicts a favourable prognosis in estrogen receptor negative and HER2 positive breast cancers. Breast Cancer Res 11(2):R15 Al-Hajj M, Wicha MS, Benito-Hernandez A et al (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100(7):3983–3988 Pardal R, Clarke MF, Morrison SJ (2003) Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 3(12):895–902 Rody A, Holtrich U, Gaetje R et al (2007) Poor outcome in estrogen receptor-positive breast cancers predicted by loss of plexin B1. Clin Cancer Res 13(4):1115–1122 Rody A, Karn T, Ruckhäberle E et al (2009) Loss of Plexin B1 is highly prognostic in low proliferating ER positive breast cancers--results of a large scale microarray analysis. Eur J Cancer 45(3):405–413 Liu R, Wang X, Chen GY et al (2007) The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 356(3):217–226 Palacios J, Honrado E, Osorio A et al (2005) Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers. Breast Cancer Res Treat 90(1):5–14 Liu S, Ginestier C, Charafe-Jauffret E et al (2008) BRCA1 regulates human mammary stem/progenitor cell fate. Proc Natl Acad Sci U S A 105(5):1680–1685 Takahashi K, Tanabe K, Ohnuki M et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861–872 Rody A, Karn T, Ruckhaeberle E et al (2008) Differentially expressed genes of reprogrammed human pluripotent stem cells in breast cancer. Eur J Cancer 44(13):1789–1792 Ben-Porath I, Thomson MW, Carey VJ et al (2008) An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40(5):499–507 Dontu G, Liu S, Wicha MS (2005) Stem cells in mammary development and carcinogenesis: Implications for prevention and treatment. Stem Cell Rev 1:207–213 Jenkins PJ (2004) Acromegaly and cancer. Horm Res 62 (Suppl):108–115 Russo J, Balogh GA, Heulings R et al (2006) Molecular basis of pregnancy-induced breast cancer protection. Eur J Cancer Prev 15:306–342 Hilakivi-Clarke L, de Assis S (2006) Fetal origins of breast cancer. Trends Endocrinol Metab 17:340–348 Wang Z, Zhang Y, Banerjee S et al (2006) Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer 106:2503–2513 Jaiswal AS, Marlow BP, Gupta N et al (2002) Betacatenin- mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)- induced growth arrest and apoptosis in colon cancer cells. Oncogene 21:8414–8427 Pahlke G, Ngiewih Y, Kern M et al (2006) Impact of quercetin and EGCG on key elements of the Wnt pathway in human colon carcinoma cells. J Agric Food Chem 54:7075–7082 Nagler A, Riklis I, Kletter Y et al (1986) Effect of 1,25 dihydroxyvitamin D3 and retinoic acid on normal human pluripotent (CFU-mix), erythroid (BFU-E) and myeloid (CFU-C) progenitor cell growth and differentiation patterns. Exp Hematol 14:60–65 Sakariassen PO, Immervoll H, Chekenya M (2007) Cancer stem cells as mediators of treatment resistance in brain tumors: Status and controversies. Neoplasia 9:882–892 Kim M, Turnquist H, Jackson J et al (2002) The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res 8:22–28 Smalley MJ, Clarke RB (2005) The mammary gland side population: A putative stem/progenitor cell marker? J Mammary Gland Biol Neoplasia 10:37–47 Litingtung Y, Lawler AM, Sebald SM et al (1999) Growth retardation and neonatal lethality in mice with a homozygous deletion in the C-terminal domain of RNA polymerase II. Mol Gen Gen 261:100–105 Phillips TM, McBride WH, Pajonk F (2006) The response of CD24(−/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 98(24):1777–1785 Li X, Lewis MT, Huang J et al (2008) Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 100:672–679 Kaufmann M, Heider KH, Sinn HP et al (1995) CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 345(8950):615–619 Abraham BK, Fritz P, McClellan M et al (2005) Prevalence of CD44/CD24–/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin Cancer Res 11:1154–1159 Balic M, Lin H, Young L et al (2006) Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res 12:5615–5621 Smid M, Wang Y, Zhang Y et al (2008) Subtypes of breast cancer show preferential site of relapse. Cancer Res 68(9):3108–3114